Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 457-459

  Khetyar, Maher ^a   Syrris, Petros ^a   Tinworth, Lorna ^a   Abushaban, Lulu ^b   Carter, Nicholas ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Chest Diseases Hospital Kuwait   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TFAP2B; TRANSCRIPTION FACTOR;

ARTICLE; CHAR SYNDROME; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONSANGUINEOUS MARRIAGE; CRANIOFACIAL MALFORMATION; FEMALE; GENE; GENE MUTATION; HAND MALFORMATION; HUMAN; MALE; MISSENSE MUTATION; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PROTEIN EXPRESSION; RNA SPLICING; TFAP2B GENE;

CONSANGUINITY; DNA MUTATIONAL ANALYSIS; DUCTUS ARTERIOSUS, PATENT; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PEDIGREE; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-2;

EID: 50649120144     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2008.0015     Document Type: Article

References (15)

1. Char F (1978) Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set ears: a new syndrome? Birth Defects Orig Artic Ser 14:303-305.
2. Coceani F (1994) Control of the ductus arteriosus: a new function for cytochrome P450, endothelin and nitric oxide. Biochem Pharmacol 48:1315-1318.
3. Davidson HR (1993) A large family with patent ductus arteriosus and unusual face. J Med Genet 30:503-505.
4. Lamy M, de Grouchy J, Schweisguth O (1957) Genetic and non-genetic factors in the etiology of congenital heart disease: a study of 1188 cases. Am J Hum Genet 9:17-41.
5. Mani A, Radhakrishnan J, Farhi A, et al. (2005) Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci USA 102:2975-2979.
6. Monge I, Krishnamurthy R, Sims D, et al. (2001) Drosophila transcription factor AP-2 in proboscis, leg and brain central complex development. Development 128:1239-1252.
7. Mullins CE, Pagotto L (1998) Patent ductus arteriosus. In: Garson AJ, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology. Baltimore, Md: Williams & Wilkins, pp 1181-1197.
8. Perloff JK (2003) Patent ductus arteriosus. In: Clinical Recognition of Congenital Heart Disease. Chapter 20, Fifth edition. Philadelphia, Pennsylvania, Saunders, p 403.
9. Polani PE, Cambell M (1960) Factors in the causation of persistent ductus arteriosus. Ann Hum Genet 24:343-357.
10. Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in genie. J Comput Biol 4:311-323.
11. Rogozin I, Milanesi L (1997) Analysis of donor splice sites in different eukaryotic organisms. J Mol Evol 45:50-59.
12. Satoda M, Pierpont MEM, Diaz GA, et al. (1999) Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. Circulation 99:3036-3042.
13. Schorle H, Meier P, Buchert M, et al. (1996) Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235-238.
14. Yagi R, Chen LF, Shigesada K, et al. (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18:2551-2562.
15. Zhao F, Weismann CG, Satoda M, et al. (2001) Novel TFAP2B mutations that cause char syndrome provide a genotype-phenotype correlation. Am J Hum Genet 69:695-703.